Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Ekaterina V SilinaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.ORCID 0000-0002-0246-5149
Natalia E ManturovaPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117997, Russia.ORCID 0000-0003-4281-1947
Elena L ChuvilinaLANHIT LLC, Moscow 105118, Russia.
Akhmedali A GasanovLANHIT LLC, Moscow 105118, Russia.
Olga I AndreevaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.
Elena B ArtyushkovaKursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.
Mikhail P GladchenkoKursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.
Aleksandr V IvanovKursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.ORCID 0000-0002-2412-0475
Victor T DudkaKursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.
Sergey Y MironovKursk State Medical University, Ministry of Health of the Russian Federation, Kursk 305041, Russia.
Daria D TkachenkoI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.ORCID 0009-0006-2691-1891
Anatoly V SkalnyI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.ORCID 0000-0002-4185-6783
Alexey A TinkovI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, Moscow 119991, Russia.ORCID 0000-0003-0348-6192
Natalia Y TabachkovaNational University of Science & Technology MISIS, Ministry of Science and Higher Education of the Russian Federation, Moscow 119049, Russia.ORCID 0000-0002-0169-5014
Victor A StupinPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117997, Russia.ORCID 0000-0002-9522-8061
Funding
Russian Science Foundation 23-65-10040
6 · The paper itself
Abstract
The aim of the study was to synthesize nanocomposites based on cerium orthophosphate stabilized with citrate at different ratios for biomedical applications, and to evaluate its safety in different animal species. Nanocomposites were synthesized using four different initial mass ratios of Ce(NO
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Novel Cerium Phosphate-Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study. · full record | OpenQuestion